The stromal composition of mast cell aggregates in systemic mastocytosis

Modern Pathology

Volumn 22, Issue 7, 2009, Pages 857-865

  Chiu, April ^b   Nanaji, Nahid M ^c   Czader, Magdalena ^d   Gheorghe, Gabriela ^d   Knowles, Daniel M ^b   Chadburn, Amy ^b,d   Orazi, Attilio ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bone marrow; Fibrosis; Mast cells; Mastocytosis; Microvessels; Stroma

Indexed keywords

NERVE GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CANCER; CELL AGGREGATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; EXTRACELLULAR MATRIX; FEMALE; FIBROGENESIS; FIBROSIS; HUMAN; HUMAN TISSUE; MALE; MAST CELL; METASTASIS; MYELOID METAPLASIA; MYOFIBROBLAST; PRIORITY JOURNAL; RETICULUM CELL; SPLEEN; STROMA CELL; SYSTEMIC MASTOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE MARROW; CELL AGGREGATION; FEMALE; FIBROSIS; HUMANS; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MICROVESSELS; MIDDLE AGED; SPLEEN; STROMAL CELLS;

EID: 67650691921     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.53     Document Type: Article

References (45)

1. Horny HP, Valent P. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 2001;25: 543-551.
2. Horny HP, Metcalfe DD, Bennett JM, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC Press: Lyon, 2008, pp 58-61.
3. Kanbe N, Kurosawa M, Nagata H, et al. Cord bloodderived human cultured mast cells produce transforming growth factor beta1. Clin Exp Allergy 1999;29: 105-113.
4. Hiragun T, Morita E, Tanaka T, et al. A fibrogenic cytokine, platelet-derived growth factor (PDGF), enhances mast cell growth indirectly via a SCF- and fibroblastdependent pathway. J Invest Dermatol 1998;111:213-217.
5. Hamada H, Vallyathan V, Cool CD, et al. Mast cell basic fibroblast growth factor in silicosis. Am J Respir Crit Care Med 2000;161:2026-2034.
6. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991;88:493-499.
7. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997;99:1313-1321.
8. Hatamochi A, Ueki H, Mauch C, et al. Effect of histamine on collagen and collagen m-RNA production in human skin fibroblasts. J Dermatol Sci 1991;2: 407-412.
9. Takeda T, Goto H, Arisawa T, et al. Effect of histamine on human fibroblast in vitro. Arzneimittelforschung 1997;47:1152-1155.
10. Thiele J, Kvasnicka HM, Facchetti F, et al. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005;90: 1128-1132.
11. Watanabe Y. Fine structure of bone marrow stroma. Acta Hematol Jpn 1985;48:1688-1700.
12. Weiss L, Sakai H. The hematopoietic stroma. Am J Anat 1984;170:447-463.
13. Mayani H, Guilbert LJ, Janowska-Wieczorek A. Biology of the hemopoietic microenvironment. Eur J Haematol 1992;49:225-233.
14. Cattoretti G, Schiro R, Orazi A, et al. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993;81:1726-1738.
15. Schmitt-Grä ff A, Skalli O, Gabbiani G. Alpha-smooth muscle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions. Virchows Arch B Cell Pathol Incl Mol Pathol 1989; 57:291-302.
16. Bonanno E, Ercoli L, Missori P, et al. Homogeneous stromal cell population from normal human adult bone marrow expressing alpha-smooth muscle actin filaments. Lab Invest 1994;71:308-315.
17. Klein G, Muller CA, Tillet E, et al. Collagen type VI in the human bone marrow microenvironment: a strong cytoadhesive component. Blood 1995;86:1740-1748.
18. Bentley SA, Alabaster O, Foidart JM. Collagen heterogeneity in normal human bone marrow. Br J Haematol 1981;48:287-291.
19. Reilly JT, Nash JR, Mackie MJ, et al. Immunoenzymatic detection of fibronectin in normal and pathological haematopoietic tissue. Br J Haematol 1985;59:497-504.
20. Mayani H. Composition and function of the hemopoietic microenvironment in human myeloid leukemia. Leukemia 1996;10:1041-1047.
21. Lisse I, Hasselbalch H, Junker P. Bone marrow stroma in idiopathic Myelofibrosis and other haematological diseases: an immunohistochemical study. APMIS 1991;99:171-178.
22. Thiele J, Rompcik V, Wagner S, et al. Vascular architecture and collagen type IV in primary myelofibrosis and polycythaemia vera: an immunomorphometric study on trephine biopsies of the bone marrow. Br J Haematol 1992;80:227-234.
23. FangW, An C, Jiang J, et al. The stromal composition of myelofibrosis: differences between chronic myeloproliferative disorders and metastatic malignancies. Mod Pathol 2003;16:232A.
24. Vega F, Medeiros LJ, Lang WH, et al. The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours. Br J Haematol 2002;117: 569-576.
25. O'Malley DP, Sen J, Juliar BE, et al. Evaluation of stroma in human immunodeficiency virus/acquired immunodeficiency syndrome-affected bone marrows and correlation with CD4 counts. Arch Pathol Lab Med 2005;129:1137-1140.
26. Caneva L, Soligo D, Cattoretti G, et al. Immunoelectron microscopy characterization of human bone marrow stromal cells with anti-NGFR antibodies. Blood Cells Mol Dis 1995;21:73-85.
27. Lewis MP, Lygoe KA, Nystrom ML, et al. Tumourderived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004;90: 822-832.
28. Papadopoulos N, Simopoulos C, Kotini A, et al. Differential expression of alpha smooth muscle actin molecule in a subset of bone marrow stromal cells, in b-cell chronic lymphocytic leukemia, autoimmune disorders and normal fetuses. Eur J Gynaecol Oncol 2001;22:447-450.
29. Apaja-Sarkkinen M, Autio-Harmainen H, Alavaikko M, et al. Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br J Haematol 1986;63:571-580.
30. Sasano H, Suzuki T. Pathological evaluation of angiogenesis in human tumor. Biomed Pharmacother 2005;59(Suppl 2):S334-S336.
31. Kvasnicka HM, Thiele J. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders. Histol Histopathol 2004;19:1245-1260.
32. Arora B, Ho CL, Hoyer JD, et al. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia. Haematologica 2004;89: 1454-1458.
33. Ponzoni M, Savage DG, Ferreri AJ, et al. Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining. Mod Pathol 2004;17:1513-1520.
34. Cervantes F, Mesa R, Barosi G. New and old treatment modalities in primary myelofibrosis. Cancer J 2007;13: 377-383.
35. Weinkove R, Reilly JT, McMullin MF, et al. Low-dose thalidomide in myelofibrosis. Haematologica 2008;93:1100-1101.
36. Damaj G, Bernit E, Ghez D, et al. Thalidomide in advanced mastocytosis. Br J Haematol 2008;141: 249-253.
37. Kluin-Nelemans HC, Ferenc V, van Doormaal JJ, et al. Lenalidomide therapy in systemic mastocytosis. Leuk Res 2009;33:e19-e22.
38. Wimazal F, Jordan JH, Sperr WR, et al. Increased angiogenesis in the bone marrow of patients with systemic mastocytosis. Am J Pathol 2002;160:1639-1645.
39. Baek JY, Li CY, Pardanani A, et al. Bone marrow angiogenesis in systemic mast cell disease. J Hematother Stem Cell Res 2002;11:139-146.
40. Baek JY, Tefferi A, Pardanani A, et al. Immunohistochemical studies of c-kit, transforming growth factorbeta, and basic fibroblast growth factor in mast cell disease. Leuk Res 2002;26:83-90.
41. Murota H, Bae S, Hamasaki Y, et al. Emedastine difumarate inhibits histamine induced collagen synthesis in dermal fibroblasts. J Investig Allergol Clin Immunol 2008;18:245-252.
42. Albrecht M, Muller K, Kohn FM, et al. Ionizing radiation induces degranulation of human mast cells and release of tryptase. Int J Radiat Biol 2007;83:535-541.
43. Orfao A, Garcia-Montero AC, Sanchez L, et al. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol 2007;138:12-30.
44. Ustun C, Corless CL, Savage N, et al. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT(D816V). Leuk Res 2009;33:735-741.
45. Aichberger KJ, Sperr WR, Gleixner KV, et al. Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis. Eur J Clin Invest 2008;38:869-873.